Temp Add

Piramal Healthcare Acquires Additional 5.5% Stake In Vodafone From Essar

By : Charmi Gutka | 6 February 2012
Industry : Telecom

COMPSPiramal Healthcare Limited will acquire 5.5% stake in Vodafone India Limited from Essar for R3007Cr.

With this deal the total shareholding of Piramal in Vodafone will increase to 11%. According to press release, the funding for investment is being met through a mix of internal and external resources.

The transaction follows the settlement between Vodafone and Essar over the sale of Essar’s approximately 33% stake in VIL, announced in July 2011, and the purchase by Piramal of approximately 5.5% of the issued share capital of VIL from Essar in August 2011.

In March 2011, Vodafone Group Plc bought Essar Group's 33% stake in JV Vodafone Essar, for $5 Bn in cash, increasing its stake from 42% to 75%. Last August, Piramal Healthcare Limited acquired 5.5% stake of Vodafone Group Plc in Vodafone Essar Limited for R2856Cr (Approx $ 640 Mn).

Essar held its stake in the JV Vodafone-Essar Ltd. through two group companies; Essar Communications (Mauritius) Ltd. owned 22%, and the remaining 11% was held by ETHL Communications.

While Essar Communications sold its entire 22% stake in July, ETHL Communications was scheduled to sell its 11% stake by Feb. 15, 2012.

In 2007, Vodafone bought a 67% controlling interest for $10.9 Bn in Hutchison Essar which was renamed as Vodafone Essar and gave option to Essar to sell its entire stake for $5 Bn or to dispose of part of the 33% shareholding at an independently appraised fair market value.

In FY10-11, PHL sold its healthcare solution business to Abbot for $ 3.8 Bn and sold stake in Piramal Diagnostics Services Private Limited to Super Religare Labs for Rs. 6.0 Bn.

PHL acquired assets of Biosyntech for C$ 4.7 Mn. Piramal Healthcare had earlier acquired 17% stake in BioSyntech in 2006. This investment gave Piramal the rights for the marketing, sales and distribution of current and future products of BioSyntech, for India and some neighbouring Asian markets.

Readers' Comments Post a Comment >>
 

KVEZAR VIEW

  DEAL TRACKER FOR
DateTransactionTypeBuyerSize ($mn)
06/02/12  Essar - Vodafone - Piramal Healthcare M&A  Piramal Healthcare Limited  616.57 
11/08/11  Vodafone Group - Vodafone Essar - Piramal Healthcare Private Equity  Piramal Healthcare Limited  624.31 
31/03/11  Essar Group (Exit) - Vodafone Essar - Vodafone Group Plc M&A  Vodafone Group Plc  5000.00 
14/05/10  Vodafone Essar - Analjit Singh M&A  Analjit Singh  76.36 
30/04/07  Vodafone Essar - IDFC PE Private Equity  IDFC Private Equity  25.00 
01/01/06  Vodafone Essar - Kotak Private Equity Exit M&A   
31/12/05  Vodafone Essar - M&A   
31/12/97  Vodafone Essar - Kotak Private Equity Private Equity  Kotak Private Equity Group 
 
  Recent Transactions In The Sector
DateTypeBuyerTargetSize ($mn)State
07/05/12   Private Equity   Looking For   Kavveri Telecom Infrastructure Limited   20.00   Planned  
16/04/12   Private Equity   GIC Special Investments Pte Limited   Tulip Telecom Limited   -   Completed  
11/04/12   M&A   Bharti Airtel Limited (Formerly Bharti Televentures Limited)   4G Licenses   1164.82   Planned  
15/03/12   M&A   Spreadtrum Communications   Micromax Informatics Limited   10.00   Completed  
 
  Profiles

Company

NamePromotersOfficeCompetitorWebsite
Piramal Healthcare Limited  Piramal Group   Piramal Tower, Ganpatrao Kadam Marg Lower Parel   Novartis India Limited
Thyrocare Technologies Limited
Ankur Drugs & Pharma Limited  
piramalhealthcare.com
Vodafone India Limited (Formerly Vodafone Essar Limited)  Essar Communications Limited
Telecom Investments India Private limited  
Peninsula Corporate Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013.   Bharti Airtel Limited (Formerly Bharti Televentures Limited)
Reliance Communications Limited
Allianz Infratech Private Limited
Tata Teleservices (Maharashtra) Limited  
www.vodafone.in
News by Sector
DealCurry Via Linkedin Facebook Twitter Blackberry. BlackBerry App DealCurry on Linkedin DealCurry on Facebook DealCurry on Twitter DealCurry Rss
Latest
e-Newsletter
Real Time Web Analytics